Gordana Milovan Smieško


Today is very well known that prostatitis is often disease in men in the age of 50 and also it make a 1/3 of urological diseases in men over 50 year old, following benign glandular prostatic hyperplasia as well cancer of prostata.

Acute bacterial prostatitis: Disturbed disorders are: general weakness, fever, pain or feeling of discomfort between the spine and the scrotum or the end of the colon, and frequent, painful and difficult urination is observed. Acute bacterial prostatitis most commonly occurs in men between the ages of 20 and 40. Disturbed disorders are: general weakness, fever, pain, or feeling of discomfort between the anus and the scrotum or in the end of the colon. In addition to the above symptoms, frequent, painful and difficult wetting occurs, and sometimes the urinary incontinence can occur. In case of suspected acute prostatitis, a prostate examination in the finishing section of the colon should be performed. The prostate is extremely painful on the touch, warm and sometimes "wet" consistency. In some cases, manure accumulation can occur within the prostate tissue, which leads to abscess (crowding), which should be surgically opened and emptied of purulent contents.

Chronic bacterial prostatitis: Due to the presence of bacteria in the tissue of the prostate, chronic bacterial prostatitis is associated with frequent recurrent acute cystitis, or inflammation of the bladder mucous membrane. In this disease, patients are mostly free from the acute phase of worsening condition.


prostatitis, acute, chronic

Full Text:



Liang CZ, Li HJ, Wang ZP,Xing JP, Hu WL, Zhang TF, et al. Treatment of chronic prostatitis in Chinese men. Asian J Androl. 2009; 11(2):153–6.

Weidner W, Wagenlehner FM, Marconi M, Pilatz A, Pantke KH, Diemer T. Acute bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: andrological implications. Andrologia. 2008; 40(2):105–12.

Nickel JC, Downey J, Johnston B, Clark J, Canadian Prostatitis Research Group. Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial. J Urol. 2001; 165(5):1539–44.

Doble A. Chronic prostatitis. Br J Urol. 1994; 74(5):537–41.

Krieger JN, Nyberg L Jr, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999; 282(3):236–7.

Weidner W, Anderson RU. Evaluation of acute and chronic bacterial prostatitis and diagnostic management of chronic prostatitis/chronic pelvic pain syndrome with special reference to infection/inflammation. Int J Antimicrob Agents. 2008; 31(Suppl 1):S91–5.

Turner JA, Ciol MA, Von Korff M, Berger R. Validity and responsiveness of the national institutes of health chronic prostatitis symptom index. J Urol. 2003; 169(2):580–3.

Propert KJ, Litwin MS, Wang Y, Alexander RB, Calhoun E, Nickel JC, et al. Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI). Qual Life Res. 2006; 15(2):299–305.

Clemens JQ, Calhoun EA, Litwin MS, McNaughton-Collins M, Kusek JW, Crowley EM, et al. Validation of a modified National Institutes of Health chronic prostatitis symptom index to assess genitourinary pain in both men and women. Urology. 2009; 74(5):983–7.

Collins MM, Stafford RS, O’Leary MP, Barry MJ. How common is prostatitis? A national survey of physician visits. J Urol. 1998; 159(4):1224– 8.

Nickel JC, Downey J, Hunter D, Clark J. Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. J Urol. 2001; 165(3):842–5.

Mehik A, Hellstrom P, Lukkarinen O, Sarpola A, Jarvelin M. Epidemiology of prostatitis in Finnish men: a population-based cross-sectional study. BJU Int. 2000; 86(4):443–8.

Roberts RO, Lieber MM, Rhodes T, Girman CJ, Bostwick DG, Jacobsen SJ. Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men. Urology. 1998; 51(4):578–84.

Calhoun EA, McNaughton Collins M, Pontari MA, O’Leary MP, Leiby BE, Landis JR.

et al. The economic impact of chronic prostatitis. Arch Intern Med. 2004; 164(11):1231–6.

Krieger JN. Classification, epidemiology and implications of chronic prostatitis in North America, Europe and Asia. Minerva Urol Nefrol. 2004; 56(2):99–107.

McNaughton Collins M, Pontari MA, O’Leary MP, Calhoun EA, Santanna J, Landis JR, et al. Quality of life is impaired in men with chronic prostatitis: the Chronic Prostatitis Collaborative Research Network. J Gen Intern Med. 2001; 16(10):656–62.

Turner JA, Ciol MA, Von Korff M, Berger R. Health concerns of patients with nonbacterial prostatitis/pelvic pain. Arch Intern Med. 2005;165(9):1054–9.

Fair WR, Parrish RF. Antibacterial substances in prostatic fluid. Prog Clin Biol Res. 1981; 75A:247–64.

Johnson JR, Kuskowski MA, Gajewski A, Soto S, Horcajada JP, Jimenez de Anta MT et al. Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis. J Infect Dis. 2005; 191(1):46–50.

Millan-Rodriguez F, Palou J, Bujons-Tur A, Musquera-Felip M, Sevilla-Cecilia C, Serrallach-Orejas M, et al. Acute bacterial prostatitis: two different sub-categories according to a previous manipulation of the lower urinary tract. World J Urol. 2006; 24(1):45–50.



  • There are currently no refbacks.

Copyright (c) 2019 Gordana Milovan Smieško

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.